De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ

J Clin Oncol. 2020 Apr 20;38(12):1252-1254. doi: 10.1200/JCO.20.00124. Epub 2020 Mar 3.

Authors

Matteo Lazzeroni¹, Andrea DeCensi^{1

2

3}

Affiliations

¹ Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
² Division of Medical Oncology, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
³ Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

PMID: 32125939
DOI: 10.1200/JCO.20.00124

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms* / drug therapy
Carcinoma, Ductal, Breast* / drug therapy
Carcinoma, Intraductal, Noninfiltrating* / therapy
Humans
Letrozole
Postmenopause
Receptors, Estrogen

Substances

Receptors, Estrogen
Letrozole